Table 6.

Correlation of HDAC mRNA expression with overall survival in different pathological grade ovarian cancer patients.

HDAC	Pathological grade	cases	HR (95% CI)	P value
HDAC1	I	56	2.24(0.83-6.1)	0.1039
	II	324	0.9(0.65-1.26)	0.5537
	III	1015	1.25(1.05-1.48)	0.011*
HDAC2	I	41	0.36(0.11-1.15)	0.0725
	II	162	1.87(1.14-3.07)	0.0122*
	III	392	1.49(1.14-1.96)	0.0038*
HDAC4	I	41	1.6(0.54-4.7)	0.3916
	II	162	1.52(0.88-2.62)	0.1324
	III	392	1.39(1.08-1.79)	0.0092*
HDAC5	I	41	3.31(0.92-11.92)	0.0527
	II	162	0.65(0.41-1.02)	0.0571
	III	392	1.49(1.16-1.91)	0.0017*
HDAC11	I	41	2.71(0.82-8.96)	0.0901
	II	162	0.78(0.49-1.25)	0.2961
	III	392	1.48(1.15-1.91)	0.0019*

*: P<0.05